Related Experiment Video

Updated: Sep 5, 2025

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

15.7K

HCV genotype 4 subtypes in people who inject drugs in sub-Saharan Africa

Matthew J Akiyama1, Mercy Nyakowa2, Lindsey R Riback1

  • 1Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY 10467, USA.

The Lancet. Gastroenterology & Hepatology
|July 9, 2022
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

18.7K
Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3
11:10

Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3

Published on: December 27, 2010

12.4K

Related Experiment Videos

Last Updated: Sep 5, 2025

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

15.7K
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

18.7K
Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3
11:10

Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3

Published on: December 27, 2010

12.4K

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

46.7K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.7K
Subviral Agents01:29

Subviral Agents

103
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
103

Articles linked to this work by shared authors, journal, and citation graph.

Gender Differences in Hepatitis C Care Outcomes in the New York City Jail System, 2019-2023: A Retrospective Cohort Study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Mitigation of COVID-19 through onsite testing and education among formerly incarcerated individuals (the MOSAIC study): an open-label, single-centre, randomised controlled trial.

The Lancet. Public health·2026

Availability of medications for opioid use disorder and hepatitis C services in New York state jails: The New York state integrated jail survey.

Public health·2026

Study protocol for the: HIV enhanced access testing in emergency department program using a systems analysis and improvement approach (HEATED-SAIA) cluster randomized trial.

Implementation science communications·2026

Budget impact of wastewater surveillance for COVID-19 in a large urban jail: an activity-based cost analysis.

Frontiers in public health·2026

Feasibility and acceptability of peer navigator-led directly-observed-therapy to promote concordance with antiretroviral therapy among criminal legal system-involved individuals.

The International journal on drug policy·2026

Aspirin after curative-intent treatment of colorectal cancer liver metastases (ASAC): a multicentre, phase 3, randomised, double-blind, placebo-controlled trial.

The lancet. Gastroenterology & hepatology·2026

Prevalence of liver fibrosis and steatotic liver disease in community-dwelling adults in China (the CHESS-LiverHealth project): cross-sectional baseline data from a prospective cohort study.

The lancet. Gastroenterology & hepatology·2026

Genetic variants and the risk of renal impairment in decompensated cirrhosis: a multi-ancestry genome-wide association study.

The lancet. Gastroenterology & hepatology·2026

Long-term outcomes of top-down therapy versus a conventional step-up strategy in adults newly diagnosed with Crohn's disease: 5-year follow-up of the PROFILE trial.

The lancet. Gastroenterology & hepatology·2026

Germline multigene panel testing for colorectal cancer: a systematic review and meta-analysis.

The lancet. Gastroenterology & hepatology·2026

ALG-055009 in non-cirrhotic adults with metabolic dysfunction-associated steatohepatitis (HERALD): a randomised, double-blind, placebo-controlled, phase 2a trial.

The lancet. Gastroenterology & hepatology·2026

Gastrointestinal adverse effects of GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists: A narrative expert review of approved therapies, oral formulations, and pipeline agents.

Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition·2026

Uncovering hypothesis-generating associations between prescription drugs and digestive cancer risk: a case-control drug-wide association study (DWAS).

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026

Real-world treatment patterns and cost per patient achieving treatment targets among tirzepatide and semaglutide initiators in US patients with type 2 diabetes.

Journal of managed care & specialty pharmacy·2026

Return on investment of SGLT2 inhibitors and GLP-1 receptor agonists: Implications of real-world use for managed care.

Journal of managed care & specialty pharmacy·2026

Trends in annual medication possession in older adults with type 2 diabetes.

Journal of managed care & specialty pharmacy·2026

The site of absorption matters: Small bowel dysmotility and levodopa pharmacokinetics in Parkinson's disease.

Journal of Parkinson's disease·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us